Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.

Abstract:

:Ornithine decarboxylase (ODC) is a rate-limiting enzyme in the first step of polyamine biosynthesis that is associated with cell growth and tumor formation. Existing catalytic inhibitors of ODC have lacked efficacy in clinical testing or displayed unacceptable toxicity. In this study, we report the identification of an effective and nontoxic allosteric inhibitor of ODC. Using computer docking simulation and an in vitro ODC enzyme assay, we identified herbacetin, a natural compound found in flax and other plants, as a novel ODC inhibitor. Mechanistic investigations defined aspartate 44 in ODC as critical for binding. Herbacetin exhibited potent anticancer activity in colon cancer cell lines expressing high levels of ODC. Intraperitoneal or oral administration of herbacetin effectively suppressed HCT116 xenograft tumor growth and also reduced the number and size of polyps in a mouse model of APC-driven colon cancer (ApcMin/+). Unlike the well-established ODC inhibitor DFMO, herbacetin treatment was not associated with hearing loss. Taken together, our findings defined the natural product herbacetin as an allosteric inhibitor of ODC with chemopreventive and antitumor activity in preclinical models of colon cancer, prompting its further investigation in clinical trials.

journal_name

Cancer Res

journal_title

Cancer research

authors

Kim DJ,Roh E,Lee MH,Oi N,Lim DY,Kim MO,Cho YY,Pugliese A,Shim JH,Chen H,Cho EJ,Kim JE,Kang SC,Paul S,Kang HE,Jung JW,Lee SY,Kim SH,Reddy K,Yeom YI,Bode AM,Dong Z

doi

10.1158/0008-5472.CAN-15-0442

subject

Has Abstract

pub_date

2016-03-01 00:00:00

pages

1146-1157

issue

5

eissn

0008-5472

issn

1538-7445

journal_volume

76

pub_type

杂志文章
  • Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.

    abstract::A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. T...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Knowles MA,Williamson M

    更新日期:1993-01-01 00:00:00

  • Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.

    abstract::Tumor metastasis is one of the most important clinical aspects of neoplastic disease because patient mortality is frequently attributable to disseminated rather than primary tumors. However, it still is not possible to definitively distinguish those individuals at high risk for disseminated disease, who would benefit ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hunter KW,Broman KW,Voyer TL,Lukes L,Cozma D,Debies MT,Rouse J,Welch DR

    更新日期:2001-12-15 00:00:00

  • Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.

    abstract::A dose-response study in carcinogenesis was carried out with N-nitrosomorpholine in female F344 rats. The compound was administered in drinking water, which was supplied in controlled amounts of 20 ml per day per rat, 5 days a wk. At the two highest dose rates, 100 mg/liter and 40 mg/liter, treatment lasted 25 and 40 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lijinsky W,Kovatch RM,Riggs CW,Walters PT

    更新日期:1988-04-15 00:00:00

  • Major alterations in the nucleotide structure of DNA in cancer of the female breast.

    abstract::DNA of invasive ductal carcinomas from five women was analyzed for structural alterations in the purine nucleotides using gas chromatography-mass spectrometry with selected ion monitoring. The results were compared to those for a normal DNA control. The carcinoma DNA showed dramatically higher concentrations of the ba...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Malins DC,Haimanot R

    更新日期:1991-10-01 00:00:00

  • Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

    abstract::When pancreatic cancer cannot be removed surgically, patients frequently experience morbidity and death from progression of their primary tumor. Radiation therapy (RT) cannot yet substitute for an operation because radiation causes fatal bleeding and ulceration of the nearby stomach and intestines before achieving tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1785

    authors: Fujimoto TN,Colbert LE,Huang Y,Molkentine JM,Deorukhkar A,Baseler L,de la Cruz Bonilla M,Yu M,Lin D,Gupta S,Cabeceiras PK,Kingsley CV,Tailor RC,Sawakuchi GO,Koay EJ,Piwnica-Worms H,Maitra A,Taniguchi CM

    更新日期:2019-05-01 00:00:00

  • Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.

    abstract::The osteolytic bone destruction associated with breast cancer skeletal metastases represents a serious and incurable clinical condition. However, the molecular mechanisms regulating tumor cell expression of factors involved in the generation of osteolytic disease remain elusive. We demonstrated recently that breast ca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3851

    authors: Barnes GL,Hebert KE,Kamal M,Javed A,Einhorn TA,Lian JB,Stein GS,Gerstenfeld LC

    更新日期:2004-07-01 00:00:00

  • Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

    abstract::Dendritic cells (DCs) are professional antigen-presenting cells, well equipped to initiate an immune response. Currently, tumor antigen-derived peptide loaded DCs are used in clinical vaccination in cancer patients. However, the optimal dose and route of administration of a DC vaccine still remain to be determined. Us...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eggert AA,Schreurs MW,Boerman OC,Oyen WJ,de Boer AJ,Punt CJ,Figdor CG,Adema GJ

    更新日期:1999-07-15 00:00:00

  • Molecular interactions of the combined effects of bleomycin and x-rays on mammalian cell survival.

    abstract::The interactions between bleomycin and X-ray damage and repair have been examined in rat and human tumor cells. Bleomycin itself indices extensive DNA single-strand breaks but does not appear to inhibit the repair of X-ray-induced DNA single-strand breaks. Quantitative analysis of these interactions is complicated by ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Byfield JE,Lee YC,Tu L,Kulhanian F

    更新日期:1976-03-01 00:00:00

  • Wnt/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis.

    abstract::Our understanding of the cellular mechanisms governing carcinoma invasiveness and metastasis has evolved dramatically over the last several years. The previous emphasis on the epithelial-mesenchymal transition as a driver of the migratory properties of single cells has expanded with the observation that carcinoma cell...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-2757

    authors: VanderVorst K,Dreyer CA,Konopelski SE,Lee H,Ho HH,Carraway KL 3rd

    更新日期:2019-04-15 00:00:00

  • APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.

    abstract::APCL, a central nervous system-specific sequence homologue of the adenomatous polyposis coli tumor suppressor, can regulate the cytoplasmic level of beta-catenin as the adenomatous polyposis coli tumor suppressor does, but its overall biological function remains unclear. Using a yeast two-hybrid system, we attempted t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakagawa H,Koyama K,Murata Y,Morito M,Akiyama T,Nakamura Y

    更新日期:2000-01-01 00:00:00

  • DNA synthesis in tumor-bearing rats.

    abstract::Thmidine (TdR) incorporation into DNA increased in the livers and spleens of rats bearing Yoshida sarcoma (solid type) or AH130 (solid type). TdR kinase and DNA polymerase activities increased in the serum, liver, and spleen of these rats, while thymidine monophosphate kinase activity increased appreciably only in the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shirasaka T,Fujii S

    更新日期:1975-03-01 00:00:00

  • Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate.

    abstract::The effect of "antiangiogenesis" therapy using cortisone acetate (CA) with or without heparin on tumor growth as well as in combination with chemotherapy was investigated. C3H mice were implanted intradermally with N-[4-(5-nitro-2-furyl)-thiazolyl]formamide induced undifferentiated transitional cell carcinoma, MBT-2, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lee K,Erturk E,Mayer R,Cockett AT

    更新日期:1987-10-01 00:00:00

  • Macrophage content of spontaneous metastases at different stages of growth.

    abstract::The macrophage content of spontaneous metastases has been quantified morphometrically for a panel of rodent tumors at different stages of metastatic tumor growth. Using a histochemical technique to selectively stain macrophages, we have evaluated the relative content of macrophages in spontaneous pulmonary metastases ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bugelski PJ,Corwin SP,North SM,Kirsh RL,Nicolson GL,Poste G

    更新日期:1987-08-01 00:00:00

  • IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.

    abstract::The class III receptor tyrosine kinase FLT3 is expressed on the blasts of >90% of patients with B-lineage acute lymphoblastic leukemias (ALL). In addition, it is expressed at extremely high levels in ALL patients with mixed lineage leukemia rearrangements or hyperdiploidy and is sometimes mutated in these same patient...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0018

    authors: Piloto O,Nguyen B,Huso D,Kim KT,Li Y,Witte L,Hicklin DJ,Brown P,Small D

    更新日期:2006-05-01 00:00:00

  • Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.

    abstract::We have synthesized fluoromycin (FLM), a novel fluorescein-labeled derivative of talisomycin S10b (TLM S10b), and used it to evaluate cellular drug accumulation and distribution in bleomycin (BLM)-sensitive and -resistant cell lines. The fluorescence intensity of FLM was 300- to 400-fold greater than that of BLM A2, T...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mistry JS,Jani JP,Morris G,Mujumdar RB,Reynolds IJ,Sebti SM,Lazo JS

    更新日期:1992-02-01 00:00:00

  • Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

    abstract::Current standard of care for patients with pediatric acute lymphoblastic leukemia (ALL) is mainly effective, with high remission rates after treatment. However, the genetic perturbations that give rise to this disease remain largely undefined, limiting the ability to address resistant tumors or develop less toxic targ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1303

    authors: Ding LW,Sun QY,Tan KT,Chien W,Mayakonda A,Yeoh AEJ,Kawamata N,Nagata Y,Xiao JF,Loh XY,Lin DC,Garg M,Jiang YY,Xu L,Lim SL,Liu LZ,Madan V,Sanada M,Fernández LT,Hema Preethi SS,Lill M,Kantarjian HM,Kornblau SM,

    更新日期:2017-01-15 00:00:00

  • Induction of cell growth regulatory genes by p53.

    abstract::Transcriptionally regulated growth-response genes play a pivotal role in the determination of the fate of a cell. p53 is known to transcriptionally regulate genes important in regulating cell growth potential. Using differential reverse transcription-PCR analysis of rat embryo fibroblast cells containing a temperature...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Madden SL,Galella EA,Riley D,Bertelsen AH,Beaudry GA

    更新日期:1996-12-01 00:00:00

  • cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.

    abstract::Data are presented indicating marked antineoplastic activity for cis-dichlorodiammineplatinum(II) in MOPC 104E myeloma. One-eighteenth of the dose that produced 100% cures can be combined with noncurative, low doses of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea to produce antineoplastic activity of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ghanta VK,Jones MT,Woodard DA,Durant JR,Hiramoto RN

    更新日期:1977-03-01 00:00:00

  • T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression.

    abstract::The relative contribution of lymphocytes, macrophages, and granulocytes to the cell content of primary 3-methyl-cholanthrene-induced murine fibrosarcomas was determined at different stages in their progression by differential cell analysis on enzyme-derived single-cell suspensions. Furthermore, immunohistological anal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wood GW,Gollahon KA

    更新日期:1978-07-01 00:00:00

  • Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

    abstract::Hereditary ovarian cancers associated with germline mutations in either BRCA1 or BRCA2 were studied to determine whether somatic mutation of the P53 gene is required for BRCA-linked ovarian tumorigenesis and further, whether the spectrum of additional somatic molecular genetic alterations present in these tumors diffe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rhei E,Bogomolniy F,Federici MG,Maresco DL,Offit K,Robson ME,Saigo PE,Boyd J

    更新日期:1998-08-01 00:00:00

  • EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.

    abstract::EphB4 receptor and its ligand ephrinB2 play an important role in vascular development during embryogenesis. In blood vessels, ephrinB2 is expressed in arterial endothelial cells (EC) and mesenchymal supporting cells, whereas EphB4 is only expressed in venous ECs. Previously, we reported that OP9 stromal cells, which s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0531

    authors: Huang X,Yamada Y,Kidoya H,Naito H,Nagahama Y,Kong L,Katoh SY,Li WL,Ueno M,Takakura N

    更新日期:2007-10-15 00:00:00

  • Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.

    abstract::A putative tumor suppressor gene, p53, has been shown to be altered in a variety of human tumor types. The primary mechanism of p53 inactivation is believed to be mutation of one allele followed by loss of the second allele. Malignant mesothelioma is a tumor that has been highly associated with exposure to asbestos fi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cote RJ,Jhanwar SC,Novick S,Pellicer A

    更新日期:1991-10-01 00:00:00

  • Nuclear factor-kappaB, an unappreciated tumor suppressor.

    abstract::The notion that nuclear factor-kappaB (NF-kappaB) is a tumor-promoting transcription factor has become a widely accepted dogma in biology. However, recent findings suggest an inhibitory role for NF-kappaB in carcinogenesis and tumorigenesis. Although the tumor suppressor-like effect of NF-kappaB remains to be rigorous...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-07-1576

    authors: Chen F,Castranova V

    更新日期:2007-12-01 00:00:00

  • Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.

    abstract::O6-Benzylguanine is an inactivator of O6-alkylguanine-DNA alkyltransferases (AGT) which is currently entering clinical trials as an agent improving the cancer chemotherapeutic activity of chloroethylnitrosoureas and other alkylating agents. O6-Benzylguanine acts by virtue of its ability to serve as a substrate for the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crone TM,Goodtzova K,Edara S,Pegg AE

    更新日期:1994-12-01 00:00:00

  • Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.

    abstract::Serial passages of the poorly differentiated, androgen-sensitive R3327-G prostatic adenocarcinoma were used to study the progressive changes that occur in tumor growth rate and androgen sensitivity. Different in vivo transplant generations (21st to 28th) were compared. The tumor doubling and animal survival times resu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pollack A,Block NL,Stover BJ,Irvin GL 3rd

    更新日期:1985-03-01 00:00:00

  • Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin.

    abstract::Identification of signaling pathways downstream of Abl tyrosine kinase may increase our understanding of the pathogenesis of chronic myelogenous leukemia (CML) and suggest strategies to improve clinical treatment of the disease. By combining the use of a phosphospecific antibody recognizing a substrate motif of serine...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ly C,Arechiga AF,Melo JV,Walsh CM,Ong ST

    更新日期:2003-09-15 00:00:00

  • Developing Cancer Informatics Applications and Tools Using the NCI Genomic Data Commons API.

    abstract::The NCI Genomic Data Commons (GDC) was launched in 2016 and makes available over 4 petabytes (PB) of cancer genomic and associated clinical data to the research community. This dataset continues to grow and currently includes over 14,500 patients. The GDC is an example of a biomedical data commons, which collocates bi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0598

    authors: Wilson S,Fitzsimons M,Ferguson M,Heath A,Jensen M,Miller J,Murphy MW,Porter J,Sahni H,Staudt L,Tang Y,Wang Z,Yu C,Zhang J,Ferretti V,Grossman RL,GDC Project.

    更新日期:2017-11-01 00:00:00

  • c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

    abstract::Amplification of the c-myc and HER2/neu genes was found in 20 and 23%, respectively, of primary breast cancer tissues derived from 282 patients (median follow-up, 74 months). c-myc amplification was observed more frequently in larger tumors (P = 0.01) and in lymph node-positive patients (P = 0.01) but was not associat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berns EM,Klijn JG,van Putten WL,van Staveren IL,Portengen H,Foekens JA

    更新日期:1992-03-01 00:00:00

  • Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.

    abstract::Emerging knowledge on how the dysregulated function of signaling networks contributes to the malignant growth of squamous cell carcinoma of the head and neck (HNSCC) can now be exploited to identify novel mechanism-based anticancer treatments. In this regard, we have observed that persistent activation of the serine/t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0921

    authors: Amornphimoltham P,Patel V,Sodhi A,Nikitakis NG,Sauk JJ,Sausville EA,Molinolo AA,Gutkind JS

    更新日期:2005-11-01 00:00:00

  • SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.

    abstract::The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast canc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1791

    authors: Oliphant MUJ,Vincent MY,Galbraith MD,Pandey A,Zaberezhnyy V,Rudra P,Johnson KR,Costello JC,Ghosh D,DeGregori J,Espinosa JM,Ford HL

    更新日期:2019-02-15 00:00:00